Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Collegium Pharmaceutical (COLL) Shares Repurchased (2021 - 2024)

Collegium Pharmaceutical has reported Shares Repurchased over the past 3 years, most recently at $25.0 million for Q4 2024.

  • Quarterly results put Shares Repurchased at $25.0 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2025 was $25.0 million (down 79.02% YoY), and the annual figure for FY2025 was $25.1 million, down 58.18%.
  • Shares Repurchased for Q4 2024 was $25.0 million at Collegium Pharmaceutical, down from $61.9 million in the prior quarter.
  • Over the last five years, Shares Repurchased for COLL hit a ceiling of $61.9 million in Q4 2022 and a floor of $25.0 million in Q4 2024.
  • Median Shares Repurchased over the past 3 years was $32.3 million (2021), compared with a mean of $39.8 million.
  • Peak annual rise in Shares Repurchased hit 91.5% in 2022, while the deepest fall reached 91.5% in 2022.
  • Collegium Pharmaceutical's Shares Repurchased stood at $32.3 million in 2021, then soared by 91.5% to $61.9 million in 2022, then crashed by 59.59% to $25.0 million in 2024.
  • The last three reported values for Shares Repurchased were $25.0 million (Q4 2024), $61.9 million (Q4 2022), and $32.3 million (Q4 2021) per Business Quant data.